KCNH6

Chr 17

potassium voltage-gated channel subfamily H member 6

Also known as: ERG-2, ERG2, HERG2, Kv11.2, hERG-2

The protein forms the pore-forming alpha subunit of voltage-gated inwardly rectifying potassium channels that regulate neuronal excitability through unusual gating kinetics, producing small outward currents during depolarization and large inward currents during repolarization. Mutations cause neurodevelopmental disorder with seizures, microcephaly, and variable intellectual disability, inherited in an autosomal dominant pattern. The gene shows extremely low constraint against loss-of-function variants (pLI near zero), suggesting the associated disorder may not result from simple protein loss.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.40
Clinical SummaryKCNH6
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
10 unique Pathogenic / Likely Pathogenic· 185 VUS of 210 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.40LOEUF
pLI 0.000
Z-score -0.53
OE 1.09 (0.851.40)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.21Z-score
OE missense 1.02 (0.961.09)
632 obs / 617.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.09 (0.851.40)
00.351.4
Missense OE1.02 (0.961.09)
00.61.4
Synonymous OE1.00
01.21.6
LoF obs/exp: 44 / 40.4Missense obs/exp: 632 / 617.6Syn Z: 0.00
DN
0.75top 25%
GOF
0.83top 10%
LOF
0.3940th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

210 submitted variants in ClinVar

Classification Summary

Pathogenic10
VUS185
Likely Benign11
Benign1
10
Pathogenic
185
VUS
11
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
10
0
10
Likely Pathogenic
0
0
0
0
0
VUS
0
184
1
0
185
Likely Benign
0
9
0
2
11
Benign
0
0
0
1
1
Total0193113207

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

KCNH6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →